Skip to content
Open in App
CSPC Pharma logo

CSPC Pharma

web2

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture an...

Symbol · CHJTF
Company profile

About

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent infection induced by chemotherapy; and Keaili for breast cancer. It also offers Shuluoke, Nuomoling, Weihong, and Xinweihong for various infections; Xuanning for hypertension; Encun to prevent atherosclerotic thrombosis events; Qixiao to treat upper respiratory tract infection; Linmeixin and Shuanglexin for diabetes; Gubang and Gubangjia to treat osteoporosis in postmenopausal women; and Gaoshunsong for arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursuitis, tenosynovitis, acute gout, dysmenorrhea, toothache and postoperative pain, low back pain, sprain, strain, and other soft tissue injuries. In addition, the company provides Debixin for various ulcer; Qimaite for acute and chronic pains; antibiotics, vitamin C, and caffeine APIs; functional food products; and healthcare services. It has a strategic collaboration with AstraZeneca PLC to advance the discovery and development of novel oral candidates, with the potential to treat diseases across multiple indications and multiple therapies for obesity and type 2 diabetes. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the People’s Republic of China.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

People

Company team

CK

Cheuk Kin Law

Independent Non-Executive Director

Company leadership profile.

BY

Bing Yao

Executive Director

Company leadership profile.

DC

Dongchen Cai

Executive Chairman

Company leadership profile.

LC

Lei Cai

CEO & Vice Chairman of the Board

Company leadership profile.

QW

Qingjie Wei

COO & Vice-Chairman of the Board

Company leadership profile.

CL

Chunlei Li

Executive Director & Chief Scientist

Company leadership profile.

ZW

Zhenguo Wang

Executive Director

Company leadership profile.

CZ

Cuilong Zhang

Executive Director

Company leadership profile.

XC

Xin Cai

Executive Director

Company leadership profile.

WC

Weiping Chen

Executive Director

Company leadership profile.

ZQ

Zhiyong Qu

Executive Director

Company leadership profile.

YZ

Yiwei Zhang

Executive Director

Company leadership profile.

CK

Chun Kwok Au

Independent Non-Executive Director

Company leadership profile.

BW

Bo Wang

Independent Non-Executive Director

Company leadership profile.

CC

Chuan Chen

Independent Non-Executive Director

Company leadership profile.

HW

Hongguang Wang

Independent Non-Executive Director

Company leadership profile.

QL

Quan Li

Independent Non-Executive Director

Company leadership profile.

Expert coverage

1 expert evaluated CSPC Pharma.

Orbitrum research

Experts evaluating CSPC Pharma

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment